I-Mab to Divest Chinese Unit for Up to $80M : vimarsana.com

By Rob Curran Biotech concern I-Mab agreed to sell its Chinese unit to affiliate I-Mab Biopharma (Hangzhou)for up to $80 million after contingencies, and it...

Related Keywords

China , San Diego , California , United States , Hong Kong , Rockville , Hangzhou , Zhejiang , Chinese , Biopharma Hong Kong , Joseph Skelton , Pamela Klein , Jingwu Zang , Richard Yeh , Raj Kannan , Rob Curran , Andrew Zhu , , I Mab Biopharma , I Mab Chief Executive Raj Kannan , I Mab Biopharma Hong Kong , I Mab Hong Kong , Article Normal , Biotechnology Services , Pharmaceuticals , Healthcare Life Sciences , Biopharmaceuticals , Biological Therapy , Healthcare Provision , Ownership Changes , Corporate Actions , Corporate Industrial News , Divestments , Content Types , Factiva Filters , C Amp Ampe Industry News Filter , Synd , I Mab , Himab , Us44975p1030 , Corporate , Industrial News , Healthcare , Life Sciences ,